肿瘤免疫微环境单细胞分析揭示胃印戒细胞癌免疫无反应性
研究纳入32例不同亚型晚期胃癌患者,用免疫靶向单细胞RNA测序(20例)和质谱流式靶向抗体panel蛋白表达谱分析(12例)刻画肿瘤免疫微环境,并行T、B细胞V(D)J测序。发现胃印戒细胞癌免疫微环境呈静息状态,CD4+与CD8+ T细胞难以被动员并进一步损害B细胞功能,CXCL13是这一转变的中心协调因子,其表达可预测胃癌患者免疫检查点阻断的疗效。
要点
- 胃印戒细胞癌肿瘤免疫微环境呈静息状态,CD4+与CD8+ T细胞难以被动员。
- CXCL13主要由滤泡辅助T细胞、辅助性T细胞17和耗竭CD8+ T细胞产生,是免疫微环境转变的中心协调因子。
- CXCL13表达可预测胃癌患者免疫检查点阻断的疗效,可能与其对三级淋巴结构的作用有关。
核心结论
- 晚期胃癌患者免疫细胞组成和细胞状态的综合分子图谱揭示胃印戒细胞癌存在适应性免疫无反应性,CXCL13在肿瘤免疫微环境中起介导作用。
- 靶向单细胞转录组和蛋白表达谱分析是面向肿瘤免疫微环境的转化研究的有效方法。
研究设计与样本
- 研究纳入32例不同亚型晚期胃癌患者,采用免疫靶向单细胞分析策略刻画肿瘤免疫微环境。
- 免疫靶向单细胞RNA测序纳入20例患者,质谱流式靶向抗体panel蛋白表达谱分析纳入12例患者。
- 对CD45+免疫细胞中的T细胞和B细胞进行匹配的V(D)J测序。
主要发现
- 与非胃印戒细胞癌相比,胃印戒细胞癌肿瘤免疫微环境呈现静息状态,CD4+和CD8+ T细胞均难以被动员,并进一步损害B细胞的正常功能。
- CXCL13主要由滤泡辅助T细胞、辅助性T细胞17和耗竭CD8+ T细胞产生,是该转变的中心协调因子。
- CXCL13表达可预测胃癌患者对免疫检查点阻断的应答,可能与其对三级淋巴结构的影响有关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Gastric cancer (GC) is a major cancer type characterized by high heterogeneity in both tumor cells and the tumor immune microenvironment (TIME). One intractable GC subtype is gastric signet-ring cell carcinoma (GSRCC), which is associated with poor prognosis. However, it remains unclear what the GSRCC TIME characteristics are and how these characteristics may contribute to clinical outcomes. METHODS: We enrolled 32 patients with advanced GC of diverse subtypes and profiled their TIME using an immune-targeted single-cell profiling strategy, including (1) immune-targeted single-cell RNA sequencing (n = 20 patients) and (2) protein expression profiling by a targeted antibody panel for mass cytometry (n = 12 patients). We also generated matched V(D)J (variable, diversity, and joining gene segments) sequencing of T and B cells along CD45+ immunocytes. RESULTS: We found that compared to non-GSRCC, the GSRCC TIME appears to be quiescent, where both CD4+ and CD8+ T cells are difficult to be mobilized, which further impairs the proper functions of B cells. CXCL13, mainly produced by follicular helper T cells, T helper type 17, and exhausted CD8+ T cells, is a central coordinator of this transformation. We show that CXCL13 expression can predict the response to immune checkpoint blockade in GC patients, which may be related to its effects on tertiary lymphoid structures. CONCLUSIONS: Our study provides a comprehensive molecular portrait of immune cell compositions and cell states in advanced GC patients, highlighting adaptive immune irresponsiveness in GSRCC and a mediator role of CXCL13 in TIME. Our targeted single-cell transcriptomic and proteomic profiling represents a powerful approach for TIME-oriented translational research.
引用
- Chen J, Liu K, Luo Y, et al. Single-Cell Profiling of Tumor Immune Microenvironment Reveals Immune Irresponsiveness in Gastric Signet-Ring Cell Carcinoma. Gastroenterology. 2023. PMID: 36921674. doi:10.1053/j.gastro.2023.03.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。